$CNXX
CONX Corp.

2020 Q3 Form 10-Q Financial Statement

#000110465920134793 Filed on December 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.530K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.530K
YoY Change
Operating Profit -$8.525K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.525K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$8.525K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$88.33
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K
YoY Change
Cash & Equivalents $220.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $220.0K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $400.0K
YoY Change
Total Long-Term Assets $358.0K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $220.0K
Total Long-Term Assets $358.0K
Total Assets $578.0K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $188.5K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $400.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $561.5K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $561.5K
Total Long-Term Liabilities $0.00
Total Liabilities $600.0K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$8.525K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $0.00
YoY Change
Total Liabilities & Shareholders Equity $578.0K
YoY Change

Cashflow Statement

Concept 2020 Q3
OPERATING ACTIVITIES
Net Income -$8.525K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 220.0K
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities 220.0K
Net Change In Cash 220.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Use Of Estimates
UseOfEstimates
<div> <div> <p style="margin:0pt 0pt 12pt 18pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Use of Estimates</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The preparation of unaudited condensed&nbsp;financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities </font><font style="display:inline;color:#000000;">at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses</font><font style="display:inline;"> during the reporting period. Actual results could differ materially from these estimates.</font> </p><div /></div> </div>
CY2020Q3 conxu Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
180000
CY2020Q3 conxu Offering Costs Included In Payables To Related Party Incurred During Noncash Or Partial Noncash Transaction
OfferingCostsIncludedInPayablesToRelatedPartyIncurredDuringNoncashOrPartialNoncashTransaction
173000
CY2020Q3 conxu Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
5000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
188525
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22844
CY2020Q3 us-gaap Assets
Assets
578000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
220000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
220000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
220000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Deferred Costs
DeferredCosts
358000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8525
CY2020Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8525
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
578000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
561525
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
220000
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-8525
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-8525
CY2020Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
373000
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
CY2020Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-8525
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8525
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
16475
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
16475
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21562500

Files In Submission

Name View Source Status
0001104659-20-134793-index-headers.html Edgar Link pending
0001104659-20-134793-index.html Edgar Link pending
0001104659-20-134793.txt Edgar Link pending
0001104659-20-134793-xbrl.zip Edgar Link pending
conxu-20200930.xml Edgar Link completed
conxu-20200930.xsd Edgar Link pending
conxu-20200930_cal.xml Edgar Link unprocessable
conxu-20200930_def.xml Edgar Link unprocessable
conxu-20200930_lab.xml Edgar Link unprocessable
conxu-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tm2036311d1_10q.htm Edgar Link pending
tm2036311d1_ex31-1.htm Edgar Link pending
tm2036311d1_ex32-1.htm Edgar Link pending